Form 4 for IDXX Idexx Laboratories
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0000874716-24-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-07 | 2024-03-05 | IDXX | Vandebroek Sophie V. | Dir | M - OptEx | $245.79 | +1,404 | 2,620 | +115% | +$345.1K |
| D | 2024-03-07 | 2024-03-05 | IDXX | Vandebroek Sophie V. | Dir | S - Sale+OE | $562.98 | -1,404 | 1,216 | -54% | -$790.4K |
| D | 2024-03-07 | 2024-03-05 | IDXX | Vandebroek Sophie V. | Dir | M - OptEx | — | -1,404 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | M | A | 1,404 | $245.79 | 2,620 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-05 | S | D | 1,404 | $562.98 | 1,216 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $562.9801 to a high of $563.2160 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-03-05 | M | D | 1,404 | — | 0 | D | $245.79 · — to 2029-05-07 | 1,404 Common Stock | (F3) Not applicable. (F2) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 6, 2020. |